5 results
6-K
EX-99.1
ARGX
Argen X SE
21 Mar 24
Current report (foreign)
6:07am
modality in multiple serious indications. The fourth key driver was to build out our innovation ecosystem, serving our core mission to sustainably … inhibitor): ARGX-119 (MuSK agonist): Build out Innovation Ecosystem In January 2024, we announced the nomination of four new pipeline candidates
6-K
EX-99.1
ARGX
Argen X SE
31 Oct 23
Current report (foreign)
9:14am
ecosystem and drive early-stage pipeline growth. argenx expects to nominate one new pipeline candidate in 2023.
THIRD QUARTER 2023 FINANCIAL RESULTS … pipeline candidate in 2023; continued investment in its Immunology Innovation Program to foster a robust innovation ecosystem and drive early-stage
6-K
EX-99.1
ARGX
Argen X SE
27 Jul 23
Current report (foreign)
6:02am
in its discovery engine, the Immunology Innovation Program, to foster a robust innovation ecosystem and drive early-stage pipeline growth. argenx expects … a robust innovation ecosystem and drive early-stage pipeline growth; the therapeutic potential of its product candidates; the intended results of its
6-K
EX-99.1
ARGX
Argen X SE
5 May 23
Current report (foreign)
8:05am
Program, to foster a robust innovation ecosystem and drive early-stage pipeline growth. argenx expects to nominate one new development candidate in 2023
- Prev
- 1
- Next